Exegenesis Bio

$7.2M revenue • 40 employees • WA, United States

Last Updated May 8, 2025

Company Overview

Company Name

Exegenesis Bio

Address

WA, United States

Approx. Annual Revenue

$7.2M

Employees

40

Established

2019

Locations

2

About Exegenesis Bio

Exegenesis Bio is a clinical-stage global cell and gene therapy company founded in 2019 with strong financial backing. The company has built a broad pipeline of innovative genetic medicines and fully integrated manufacturing capabilities, focused on the development of gene therapies for central nervous system, ophthalmology, and liver diseases.

Business Profile

Read from the Exegenesis Bio website on Oct 14, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright 2026; Complete company information
Footer copyright year
2026

Recent changes

What changed on the Exegenesis Bio website and Google listing, as detected by Coldlytics on each visit.

  1. Started advertising open roles

  2. Estimated revenue band moved from $1M-2.5M to $5M-10M

  3. Estimated headcount moved from 11-20 to 21-50 employees

Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.

Find companies by what just changed →

Exegenesis Bio locations

2 Google Business Profile listings.

LocationGoogle categoryReviewsStatus
WAprimary———
206 Welsh Rd, Horsham, PA——Claimed

Biotech & Life Sciences Companies near WA

Browse all Biotech & Life Sciences companies in Washington →

Frequently Asked Questions about Exegenesis Bio

Categories

Technologies Used

Social Profiles

Key Decision Makers

Zhenhua Wu CEO
LinkedIn
Meghan Wedeking Clinical Trials and Regulatory Associate
LinkedIn